Skip to main navigation
Oyster Point Pharma Oyster Point Pharma Oyster Point Pharma Oyster Point Pharma
This site is intended for US audiences only
  • Investors & Media
    • News & Events
      • News Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Committee Composition
    • Financial Information
      • SEC Filings
    • IR Resources
      • FAQs
      • Information Request
      • Email Alerts
  • Careers
  • Contact
LinkedIn Twitter Search
  • Who We Are
  • Science & Pipeline
  • Our Focus
  • Our Therapies
Oyster Point Pharma Oyster Point Pharma
LinkedIn Twitter
  • Who We Are
  • Science & Pipeline
  • Our Focus
  • Our Therapies
  • Investors & Media
    • News & Events
      • News Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Committee Composition
    • Financial Information
      • SEC Filings
    • IR Resources
      • FAQs
      • Information Request
      • Email Alerts
  • Careers
  • Contact

This site is intended for US audiences only

News Releases

Breadcrumb

  1. Home
  2. Investors
  3. news and events
  4. News Releases
May 05, 2022
Oyster Point Pharma Reports First Quarter 2022 Financial Results and Recent Business Highlights
PDF Version
May 03, 2022
Oyster Point Pharma To Report First Quarter 2022 Financial Results On May 5, 2022
PDF Version
Apr 27, 2022
Oyster Point Pharma to Present New Analyses at the Association for Research in Vision and Ophthalmology (ARVO) 2022
PDF Version
Apr 19, 2022
Oyster Point Pharma to Present New Clinical Data at the American Society of Cataract and Refractive Surgery (ASCRS) 2022
PDF Version
Mar 17, 2022
Oyster Point Pharma Announces Retirement of William J. Link From Board of Directors
PDF Version
Mar 01, 2022
Oyster Point Pharma to Participate in the Cowen 42nd Annual Health Care Conference
PDF Version
Feb 24, 2022
Oyster Point Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
PDF Version
Feb 22, 2022
Oyster Point Pharma Announces TYRVAYA™ Nasal Spray Now Covered by Express Scripts
PDF Version
Feb 16, 2022
Oyster Point Pharma To Report Fourth Quarter And Full Year 2021 Financial Results On February 24, 2022
PDF Version
Jan 04, 2022
Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PDF Version

Shareholder Tool

Print Page button Print Page
Email Alerts button Email Alerts
Information Request button Information Request
OysterPointRX

Footer Links

  • Who We Are
  • Science & Pipeline
  • Our Focus
  • Investors & Media
  • Careers
  • Contact Us

Legal Links

  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2022 Oyster Point Pharma, Inc., TYRVAYA™, and the Oyster Point logo are trademarks of Oyster Point Pharma, Inc.
We use cookies to deliver our online services. Details of the cookies can be found by clicking the 'Cookie settings' link. To agree to our use of cookies click 'Accept.'. Cookie settings ACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. The cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We...
Necessary
Always Enabled
SAVE & ACCEPT